ough we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these forward-looking statements or the "Risk Factors" contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.
(1) Berkow L., Rotolo S., Mirski E. "Continuous and Noninvasive Hemoglobin Monitoring During Complex Spine Surgery." Johns Hopkins School of Medicine, Baltimore, Maryland. Presented at the STA Annual Meeting January 12-15, 2011.
(2) Bernard AC et al. Intraoperative transfusion of 1U to 2U of packed red blood cells is associated with increased 30-day mortality, surgical site infection, pneumonia, and sepsis in general surgery patients. Journal of the American College of Surgeons. 2009;208:931-937.
(3) Surgenor SD et al, for the Northern New England Cardiovascular Disease Study Group. The Association of Perioperative Red Blood Cell Transfusions and Decreased Long-Term Survival After Cardiac Surgery. Anesthesia & Analgesia 2009; 108:1741-1746.
Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care… by Taking Noninvasive Monitoring to New Sites and Applications, rainbow, Pulse CO-Oximetry, Pulse CO-Oximeter, SpHb, SpOC, SpCO, SpMet, PVI, rainbow Acoustic Monitoring, RRa, Radical-7, Rad-87, Rad-57, Rad-8, Rad-5, Pronto-7, Pronto, Patient SafetyNet, and SEDLine are trademarks or registered trademarks of Masimo Corporation.Media Contacts: Dana BanksMasimo Corporation(9Page: 1 2 3 4 5 6 Related biology technology :1
. Dr. Eric Johnson Joins Transgenomic as Medical Director for Laboratory Services2
. Johnson & Johnson and Crucell Reach Agreement on Intended Public Offer of Euro 24.75 per Ordinary Share of Crucell3
. aTyr Pharma Appoints Catharine E. Johnson As Senior Vice President of Business Development4
. The New York Stem Cell Foundation and The Johns Hopkins University School of Medicine to Collaborate on Stem Cell Research5
. Johnson & Johnson Consumer Companies, Inc., Unveils CYTOMIMIC(TM) Technology at 68th Annual Meeting of the American Academy of Dermatology6
. iPierian to Collaborate With Johns Hopkins University on $3.7 Million NIH Grand Opportunities Grant7
. Johnson & Johnson Honors 2009 Recipient of The Dr. Paul Janssen Award for Biomedical Research8
. Cempra Pharmaceuticals Announces Appointment of John H. Johnson to Board of Directors9
. SmartGenes Services for Faster, More Precise Identification of Bacteria and Fungi to be Used by The Johns Hopkins Hospital10
. Johnson & Johnson Completes Acquisition of Cougar Biotechnology11
. Professor Fisher receives ASEEs Beer and Johnston Award